February 26, 2018

---

NewLeaf Symbiotics launches transformative ag biological technology - Terrasym products sold in the US market for the first time

September 8, 2017

---

Agriculture biologicals company NewLeaf Symbiotics announces second close to complete its $30MM C round financing - New capital reflects company’s leadership in consumer driven desire for sustainability 

July 11, 2017

---

Ag biotech company NewLeaf Symbiotics announces $24MM series C financing - New capital will support expansion and product commercialization

June 5, 2017

---

NewLeaf Symbiotics hires Formulations Manager - Skilled formulations scientist joins agricultural biologicals company

April 26, 2017

---

NewLeaf Symbiotics hires plant researcher and patent agent - Two highly-skilled professionals join agricultural biologicals company

August 18, 2016

---

NewLeaf Symbiotics secures key patents in Europe and Japan

July 19, 2016

---

NewLeaf Symbiotics appoints VP for Research and Discovery - Microbial expert joins agricultural biologicals company 

May 17, 2016

---

NewLeaf Symbiotics rapidly grows in key expertise - New team members will accelerate the biological ag company

March 23, 2016

---

Biologicals included in quest for 2050 (Agri-View)

February 18, 2016

---

Biologicals in quest for 2050: Syngenta (Agri-View)

November 13, 2015

---

NewLeaf Symbiotics receives key US production patent for its Microbial Fermentation technology (Bio.IT.World)

April 30, 2015

---

NewLeaf Symbiotics continues to grow expertise

March 12, 2015

---

NewLeaf Symbiotics recruits leading business development and commercialization expert  Mike McFatrich as Vice President for Business Strategy and Development

September 16, 2014

---

Silicon Valley investor Otter Capital leads NewLeaf Symbiotics’ $17 million funding (St. Louis Business Journal)

April 24, 2014

---

Agtech startup NewLeaf Symbiotics eyes product development growth (St. Louis Business Journal)

December 9, 2013

---

NewLeaf Symbiotics acquires Intuitive Genomics - Combination of biologicals and big data  creates opportunities for investors